PAIN
Volume 139, Issue 3 , Pages 603-609 , 31 October 2008

Fast non-genomic effects of progesterone-derived neurosteroids on nociceptive thresholds and pain symptoms

Received 2 April 2008 ,Revised 10 June 2008 ,Accepted 10 June 2008.

References 

  1. Akk G, Shu HJ, Wang C, Steinbach JH, Zorumski CF, Covey DF, et al. Neurosteroid access to the GABAA receptor. J Neurosci. 2005;25:11605–11613
  2. Biggio G, Concas A, Follesa P, Sanna E, Serra M. Stress, ethanol, and neuroactive steroids. Pharmacol Ther. 2007;116:140–171
  3. Brussaard AB, Devay P, Leyting-Vermeulen JL, Kits KS. Changes in properties and neurosteroid regulation of GABAergic synapses in the supraoptic nucleus during the mammalian female reproductive cycle. J Physiol. 1999;516:513–524
  4. Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol. 2000;21:1–56
  5. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438:1017–1021
  6. Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, et al. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature. 2003;424:938–942
  7. Devaud LL, Purdy RH, Morrow AL. The neurosteroid, 3 alpha-hydroxy-5 alpha-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol Clin Exp Res. 1995;19:350–355
  8. Frye CA. The neurosteroid 3 alpha, 5 apha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 1995;696:113–120
  9. Frye CA, Duncan JE. Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats. Brain Res. 1994;643:194–203
  10. Frye CA, Walf AA, Rhodes ME, Harney JP. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase. Brain Res. 2004;1004:116–124
  11. Gasior M, Carter RB, Witkin JM. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol Sci. 1999;20:107–112
  12. Girdler SS, Klatzkin R. Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol Ther. 2007;116:125–139
  13. Guirimand F, Le Bars D. Physiology of nociception. Ann Fr Anesth Reanim. 1996;15:1048–1079
  14. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88
  15. Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, et al. GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science. 2004;304:884–887
  16. Herd MB, Belelli D, Lambert JJ. Neurosteroid modulation of synaptic and extrasynaptic GABA(A) receptors. Pharmacol Ther. 2007;116:20–34
  17. Hosie AM, Wilkins ME, da Silva HM, Smart TG. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature. 2006;444:486–489
  18. Ishikawa T, Marsala M, Sakabe T, Yaksh TL. Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist. Neuroscience. 2000;95:781–786
  19. Jiang P, Yang CX, Wang YT, Xu TL. Mechanisms of modulation of pregnanolone on glycinergic response in cultured spinal dorsal horn neurons of rat. Neuroscience. 2006;141:2041–2050
  20. Kavaliers M, Wiebe JP. Analgesic effects of the progesterone metabolite, 3 alpha-hydroxy-5 alpha-pregnan-20-one, and possible modes of action in mice. Brain Res. 1987;415:393–398
  21. Keller AF, Breton JD, Schlichter R, Poisbeau P. Production of 5alpha-reduced neurosteroids is developmentally regulated and shapes GABA(A) miniature IPSCs in lamina II of the spinal cord. J Neurosci. 2004;24:907–915
  22. Le Foll F, Castel H, Louiset E, Vaudry H, Cazin L. Multiple modulatory effects of the neuroactive steroid pregnanolone on GABAA receptor in frog pituitary melanotrophs. J Physiol. 1997;504:387–400
  23. Luis-Delgado OE, Barrot M, Rodeau JL, Schott G, Benbouzid M, Poisbeau P, et al. Calibrated forceps: a sensitive and reliable tool for pain and analgesia studies. J Pain. 2006;7:32–39
  24. Maguire J, Mody I. Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress. J Neurosci. 2007;27:2155–2162
  25. McEwen BS. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 1991;12:141–147
  26. Mellon SH. Neurosteroid regulation of central nervous system development. Pharmacol Ther. 2007;116:107–124
  27. Meyer L, Venard C, Schaeffer V, Patte-Mensah C, Mensah-Nyagan AG. The biological activity of 3alpha-hydroxysteroid oxido-reductase in the spinal cord regulates thermal and mechanical pain thresholds after sciatic nerve injury. Neurobiol Dis. 2008;30:30–41
  28. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol. 1999;57:1–164
  29. Mitchell EA, Gentet LJ, Dempster J, Belelli D. GABAA and glycine receptor-mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids. J Physiol. 2007;583:1021–1040
  30. Morrow AL. Recent developments in the significance and therapeutic relevance of neuroactive steroids – Introduction to the special issue. Pharmacol Ther. 2007;116:1–6
  31. Poisbeau P, Feltz P, Schlichter R. Modulation of GABAA receptor-mediated IPSCs by neuroactive steroids in a rat hypothalamo-hypophyseal coculture model. J Physiol. 1997;500:475–485
  32. Poisbeau P, Patte-Mensah C, Keller AF, Barrot M, Breton JD, Luis-Delgado OE, et al. Inflammatory pain upregulates spinal inhibition via endogenous neurosteroid production. J Neurosci. 2005;25:11768–11776
  33. Rupprecht R, Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 1999;22:410–416
  34. Rupprecht R, Reul JM, Trapp T, van Steensel B, Wetzel C, Damm K, et al. Progesterone receptor-mediated effects of neuroactive steroids. Neuron. 1993;11:523–530
  35. Schlichter R, Keller AF, De Roo M, Breton JD, Inquimbert P, Poisbeau P. Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways. J Mol Neurosci. 2006;28:33–51
  36. Schlichter R, Rybalchenko V, Poisbeau P, Verleye M, Gillardin J. Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine. Neuropharmacology. 2000;39:1523–1535
  37. Sivilotti L, Woolf CJ. The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J Neurophysiol. 1994;72:169–179
  38. Vergnano AM, Schlichter R, Poisbeau P. PKC activation sets an upper limit to the functional plasticity of GABAergic transmission induced by endogenous neurosteroids. Eur J Neurosci. 2007;26:1173–1182

PII: S0304-3959(08)00326-6

doi: 10.1016/j.pain.2008.06.016

PAIN
Volume 139, Issue 3 , Pages 603-609 , 31 October 2008

Article Tools

* Image Usage & Resolution